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Background/aim: This study aims to serve as a unique consolidated source in Turkey’s vaccination history and as an example for other
countries by objectively revealing the change in mortality and morbidity rates in Turkey following the beginning of vaccination without
asserting any claim on the benefits or risks of vaccines. This unbiased research will also help health professionals identify the challenges
more easily when they face with the people who hesitate to vaccinate their children.
Materials and methods: Descriptive research design is adopted in this study. The coverages of vaccinations, mortality, and morbidity
rates were identified through a retrospective analysis of the data provided from the Ministry of Health of Turkey. The data provided
by the Turkish Statistical Institute were used for the identification of the population by the year. Mortality and morbidity rates were
calculated based on these data
Results: Morbidity rates, mortality rates, and vaccine coverages are all presented in years. Successful interventions have been observed
in the eradication of polio, the elimination of maternal neonatal tetanus, and also in combating with other diseases. A decline in
pertussis mortality from 0.59 to 0.06 along with a decline in diphtheria morbidity under to 0.0001 were recognized; additionally the
last death due to poliomyelitis was observed in 1998. Only 4 deaths occurred in the measles epidemic in 2013. With the initiation of
vaccination, both the morbidity of the rubella with the ratio of 3.12/100,000 and the mortality of pumps with the ratio of 25/100,000 fell
to zero. Also, no death due to neonatal tetanus has been recorded since 2014.
Conclusion: The present study demonstrates that many possible diseases and deaths have been prevented through vaccination studies.
In this regard, this study demonstrating the importance of vaccination presents that all individuals in the society have a responsibility
in this scope when the communicable diseases and wars are taken into consideration. The main responsibility is to ensure that they and
their children are vaccinated against communicable diseases that are risky for society’s health.
Key words: Vaccination, vaccine-preventable diseases, communicable diseases, immunization

1. Introduction
It has been observed that the microorganisms led to
radical changes in political and social structures in
communities by causing outbreaks with the emergence
of the communicable diseases such as plague, smallpox,
typhus, typhoid, cholera, influenza, and malaria [1].
Today, an up-to-date vaccination schedule is
established in Turkey with the gradual development
of new vaccines, strains, and application methods.
Vaccine schedules and vaccination coverages are
constantly changing and improving thanks to the recent
developments in technology. The Expanded Programme
on Immunization (EPI) consisting of the rules to be
observed for management of the nationwide and provincial
immunization services in Turkey became effective as of

1981.The main purpose of the EPI is to vaccinate every
newborn baby against diseases through the immunization
schedule. The word “expanded” is used to emphasize
that unvaccinated or incomplete vaccinated babies and
children should be vaccinated as soon as they are detected
and that this implementation must be maintained evenly
everywhere throughout the country. Besides, EPI has
many goals such as: reaching 95% vaccination coverages
across the country, eliminating tetanus, neonatal tetanus
as well as such diseases related to diphtheria, pertussis,
hepatitis-b, tuberculosis, mumps, hemophilus influenza
type b, and also controlling invasive pneumococcal
diseases related to streptococcus pneumonia, maintaining
vaccine safety, strengthening the notification system and
ensuring the participation of the community. Three new
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agents (rubella, mumps, and hemophilus influenza type
b) have been added to the vaccination schedule in EPI
since 2006. Since 2008, the pentavalent vaccine including
DaPT-IPV-Hib and the conjugated pneumococcal vaccine
have been launched. Constantly supported by elimination
and eradication programs and with the improvements in
recording and notification systems, EPI is becoming more
effective day by day [2,3].
On the other hand, the World Health Assembly aimed
to eradicate poliomyelitis from all over the world until
2000. Surveillance and laboratory investigations have
been initiated in Turkey towards acute flaccid paralysis
cases under the age of 15 in compliance with the aim of
eradication of poliomyelitis [4].
In Turkey, also pertussis and diphtheria case records
are laboratory-supported and case-based surveillance
systems [5].
Surveillance studies for viral hepatitis (Only Hepatitis-A
and Hepatitis-B) are ongoing, but case-based data for these
diseases have not been collected. Although endemicity
continues for chickenpox and mumps throughout the
country; no confirmed data has been collected, besides,
no monitoring case-based and laboratory-supported data
exist for these diseases [5].
In order to have a strong surveillance system on data,
laboratory-supported definitive case surveillance has
been started as of 2005. Including Measles, Rubella, and
Congenital Rubella Syndrome Elimination Program, casebased and necessarily confirmed or epidemiologically
related cases are considered as confirmed cases and specific
surveillance is carried out based on WHO standards.
Today, campaigns against vaccines started to be
conducted through social media or other mass media
platforms. As a result of these campaigns, the debates on
the harm of vaccines have increased and vaccine hesitancy
and refusal have consequently scaled up all over the world
and took place in the WHO’s list of 10 threats to global
health in 2019. Therefore, this brief report was written
with the aim of being a collective single source in regards
to the history of vaccination in the country, providing an
example to other countries, and supporting the health
professionals to raise awareness of the parents with vaccine
hesitancy for their children having possible risks while
taking the parents’ decisions on vaccination. This study
presents the figures on mortality and morbidity rates seen
before the implementation of vaccination in Turkey and
also the changes in those figures after the vaccination
practices are imposed in Turkey as a result of the gradual
developments. The results aim to impartially demonstrate

the difference which may affect the decision of the people
who have vaccine hesitancy without clearly claiming the
benefits of vaccination.
2. Materials and methods
The number of mortality and morbidity was identified
through a retrospective analysis of the archival records
provided from the Ministry of Health of Turkey. In the
records of the Ministry of Health, mortality rates were
calculated for 1.000.000, while it was 100,000 for morbitiy
rates. Mortality and morbidity rates based on these data
and vaccination coverages based on WHO data1 were
compared in figures. The data of Turkish Statistical
Institute2 were used for the identification of the population
by years.
The fact that the registration system for different
diseases was initiated in different dates and in turn, the
related graphics were enabled only after the launch of
registration can be considered the limitation of this study.
Also, there is no full confidence behind the vaccine records
kept on papers used before the electronic registration
system.
3. Results
The evaluation of vaccination activities, the number
of cases and deaths in the country, and the years when
vaccines were introduced into the routine vaccination
schedule are presented in Table. Diphtheria and pertussis
vaccine came into use in 1937, then the Polio vaccine
was started to be used in 1963 with the attenuated form.
After the start of the Polio eradication program in 1989,
polio national vaccination days were implemented in 1995
and 1996. Measles immunization started in 1970 and the
measles elimination program has been maintained since
2002. With the start of the measles elimination program,
Measles school vaccination days (2003) and Measles
vaccination days (2005) were organized. Hib, Mumps, and
Rubella were added to the routine vaccination schedule
in 2006. Hep B immunization started in 1998 and Hep A
started in 2012 (Table).
While the mortality rate (per 100.000) of pertussis
was 0.59, it decreased below 0.1 after immunization. The
mortality rate of diphtheria was nearly 2 in 1970 and is
always under 0.01 after 1990. When neonatal tetanus was
recorded in the 1990s, the mortality rate was 16.9 and
showed fluctiations until 2006. In 2004, the Td vaccine
application was started for adult vaccination and in 2009,
the maternal-neonatal tetanus elimination program was
started (Table). In 2010, the morbidity rate decreased to
0.16 and the mortality rate to 1.55 and did not increase

World Health Organisation (2020). Spreadsheet of the vaccinaton of countries [online]. Website https://apps.who.int/immunization_monitoring/
globalsummary/ timeseries/ tscoveragedtp3.html [accessed 10.09.2020]
1

Turkish Statistical Institute (2019). The Population Statistics by years, age group and sex 1935-2019 document [online]. Website http://www.tuik.gov.tr/
Preistatistik Tablo.do?istab_id=1588 [accessed 10.09.2020]
2
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Table. National immunization schedule performed in Turkey [2].
1937 Diphteria, Pertussis Immunization
1952 BCG Immunization
1963 Live Polio Immunization
1968 DTP Immunization
1970 Measles Immunization
1981 Expanded Programme on Immunization
1985 Vaccine Campaign in Turkey
1989 Poli Eradication Programme
1995 Polio National Immunization Days
1996 Measles Vaccination Acceleration Campaign
1997 Polio Mop‐Up
1998 Last Polio Case and Hepatitis B İmmunization
2003 Vaccination Days at Schools for Measles
2004 Initiation of Td vaccine for adults in necessary situations
2005 Measles Vaccination Days
2006 Addition of Hib, Mumps, Rubella Vaccines to Vaccination Schedule, Initiation of Hepatitis B Immunization for Adolescents
2007 Completion of Hepatitis B and Rubella Vaccines in Elementary students
2008 Administration of Pentavalent (DTP-Polio and Hib) Vaccine
2008 Inclusion of a Heptavalent Pneumococcal Conjugate Vaccine to Vaccination Schedule
2009 Elimination of Maternal-Neonatal Tetanus
2010 Initiation of DTP and IPV vaccines instead of live polio and Td vaccines at 1. Grade of Elementary School
2011 Initiation of 13-Valent Pneumococcal Conjugate Vaccine
2012 Hepatitis A Immunization
2013 Adding Chickenpox Vaccine to Current Vaccination Schedule

again. On the other hand, considering the country
vaccination status, there was a decrease in DaPT coverage,
also an increase in neonatal tetanus deaths towards 1995.
DaPT coverages have increased since 2003 and neonatal
tetanus progressively decreased. While the Polio mortality
rate was 1.1 in 1970, the number of cases and deaths
decreased rapidly with vaccination campaigns and the last
case was seen in 1998. The measles mortality has decreased
to zero before 1990s with the effect of vaccinations that
started to be used in 1970. Mumps vaccination was added
in 2006 and coverages were always at high levels. Mumps
morbidity rate was over 25 in 2006 and became almost
zero in a few years (Figure 2).
The increase of pertussis immunization decreases the
morbidity. The morbidity rate (per 100.000), which was
20.58 in 1970, decreased to 0.8 in 1990. The strong decline
in vaccination in 1995 seems to somewhat negatively affect
morbidity. The diphtheria morbidity rate was almost 3 in
1970 and it was under 0.01 after 2000. The immunization
records of measles begin in 2006, coverages are always 94
and mostly over 96. Measles morbidity rates were stable

after 2004 and are very low in the chart (Figure 2). The
rubella morbidity rate was 3.12 in 2005. Rubella vaccination
begins in 2006, and the morbidity rate in 2006 was 1.45,
which dropped drastically over the years. The morbidity
rate for hepatitis B peaked and reached almost 12 in 2005.
Immunization started in 2006 and was generally at high
levels. A moderate decrease in mortality rates is also
observed after vaccination; however, associating this fact
to vaccination is difficult. Since hepatitis A vaccination
records were not available, they were not included in the
vaccination chart. Hepatitis B morbidity, on the other
hand, performed the last peak before vaccination in 2005
and decreased from 12 to 2 in 2017 (Figure 2).
The comparision of mortality rates (per 100.00) and
vaccine coverages by years are given in Figure 1. The
comparision of morbidity rates (per 100.000) and vaccine
coverages by years are given in Figure 2.
4. Discussion
In general, the debate on the necessity and side effects
of vaccines existed in human history for more than
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Figure 1. The comparision of mortality rates (per 1.000.000) and immunization coverages by years. The line chart shows vaccine
coverages, and as it is shown with numbers on the right side, it increases from 0 to 100 from 1970 to 2020. As the immunization records
started at 1990, the lines start at 1990. DaPT line represents Diphteria, Pertussiss, and Tetanus; MMR line represents Mumbs, Measles,
and Rubella; Pol3 represents Polio; Hep_B represents Hepatitis B; Hib represents H.influenza type b. The dot plot in the figure represents
mortality rates. As it can be seen by numbers on the left side, the mortality rate increases from 0 to 25 (per 1.000.000), when the timeline
goes from 1970 to 2020.

Figure 2. The comparision of morbidity rates (per 100.000) and vaccine coverages by years]. The line chart shows vaccine coverages,
and as it is shown with numbers on the right side, it increases from 0 to 100 from 1970 to 2020. But immunization records usually
started at 1990, the lines start at 1990. DaPT line represents Diphteria, Pertussiss, and Tetanus; MMR line represents Mumbs, Measles,
and Rubella; Pol3 represents Polio; Hep_B represents Hepatitis B; Hib represents H.influenza type b. The dot plot in the figure shows
morbidity rates. As it can be seen by the numbers on the left side, the mortality rate increases from 0 to 125 (per 100.000), when the
timeline goes from 1970 to 2020.

200 years still continues today, so elaboration is very
important to show the change in mortality and morbidity
of communicable diseases with the introduction of
vaccination.
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In previous years, there may be doubts about the
trustworthy of the records due to reasons such as not
keeping the records of vaccination and cases or deaths
electronically and meticulously as they are now, and not
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tracking vaccines with barcodes. However, it is assumed
that the morbidity and mortality rates in those years were
not less than the ones presented in this study; instead, they
may be higher than given. While the recording systems have
been gradually developed, the numbers have decreased
and sometimes increased due to various reasons. To make
it easier to understand, vaccination activities and changes
in case numbers are presented by years as well as the
examples across the world and comparisons respectively.
Lastly, related debates took place in discussion section for
each vaccine starting from the years when they were first
introduced in the country.
4.1. Diphtheria- Pertussis -Tetanus- Neonatal Tetanus
Diphtheria and pertussis vaccine was applied for the first
time in 1937 in Turkey (Table). While the mortality rate
of pertussis cases was 0.59 in 1970, it declined rapidly to
under 0.1 after the beginning of the DaPT immunization.
The morbidity rate which was 20.58 in 1970 became
0.50 after 1990; however, the effect of a strong spike to
bottom of immunization coverages in 1995 made pertussis
morbidities visible again in mild degree over of the zero
line in Figure 2. The pertussis morbidity rate was over 1 in
1996 and 1997.
As the diphteria morbidity rate is almost 3 in 1972, it
is obvious on Figure 2. After 2000, together with other
effects; it dropped under 0.01 and it has been going under
0.0001 thank to vaccination. The mortality rate was
around 2 in 1970’s while it was under 0.01 just before 1990,
in parallel to the success with diphteria has been ongoing
since 1990 with the contribution of immunization, as well.
The first neonatal tetanus deaths were reported in 1990
and is visible in orange in Figure 1 and it was over 20 at
the beginning of the recordings. In 2009, Maternal-Infant
tetanus elimination program was implemented all around
Turkey. Elimination program is still in force. Although
tetanus cases, related morbidities and mortalities are just
a few all over Turkey, small fluctuations can be seen from
time to time.
After the effective vaccination campaigns, no newborn
babies have died in Turkey due to neonatal tetanus
since 2014. However, while tetanus morbidity had been
decreasing until 2007 and the morbidity increased due to
tetanus between 2008–2017. Adult vaccinations should be
encouraged to protect infants in combating diseases such
as tetanus that do not develop permanent immunity [6].
4.2. Poliomyelitis
The administration of Atennue Polio vaccine started in
1963 in Turkey. The mortality rates for Poliomyelitis in
1970 were 1.10. In 1989, Polio eradication program was
started and Polio national vaccination days and Polio
Mop-Up campaigns were performed in 1995 and 1997.

After all this efforts, the last case was seen in 1998. (Table).
There is a risk in Turkey in terms of polio disease due
to the migration after the civil war was broken out in Syria.
To eliminate this risk, Turkey has started vaccinating all
Syrian children and 5 million children under age 5 in 7
provinces before they enter the camps located near Syria.
Turkey reached a vaccination rate of almost 90% with
successful vaccination campaign. Thus, no polio cases
have been reported and maybe possible child deaths
have been prevented. However, the failure to implement
strategic approaches causes the virus to continue to live
and infect children. It is stated that if polio does not
stop and spreads in Afghanistan, Nigeria, and Pakistan,
where the virus is endemic, it can cause the emergence of
200,000 new cases annually worldwide3. Consequently, it
should be remembered that in the globalized world where
transportation is now very easy, infectious diseases are
considered as a problem that should be adressed not only
by the endemic countries but the all countries in the world.
The coverage has had a decent line since 2007 (Figure1 and
2).
4.3. Measles
Although measles vaccination application initiated in
1970, immunization coverage data is started to be kept
since 2006. However, the immunization effect on measles
can be easily understood by looking at the mortality chart
(Figure 1), because there has been a linear decline since
1970 towards 1985 without immunization data. Looking
at the morbidity, we can say that there is a stable status
since 2004, because we clearly observe the impact of the
measles elimination campaings in 2005 (Table and Figure
2). According to the vaccine coverage data started to be
kept in 2006, this vaccine coverage, which is always over
94% and mostly 96% or above since this year, is the reason
of this stable status.
Since 2002, the Ministry of Health has implemented
the Measles Elimination Program. Measles vaccination
days were organized at schools in 2003 and schoolage children were immunized. Turkey has continued
its commitment to the elimination of measles by
implementing measles vaccination days for the second
time in 2005. The significant impact of the second dose
of vaccine, which was added in 1998 and administered to
first-year children in school age, has been observed since
2001 (Table and Figure 2). From 2007 to 2011, the number
of cases remained below 5, and no domestic cases were
seen between 2008 and 2010. However, after the civil war
broken out in 2011 in Syria and the measles outbreak in
Europe because of suboptimum vaccination coverage, the
morbidity rates started to increase rapidly and an epidemic
was experienced in 2013 and the morbidity rates reached
nearly 10 (there is an overlap between measles and varicella

World Health Organisation (2019). Poliyomyelitis factsheets [online] Website https://www.who.int/news-room/fact-sheets/detail/poliomyelitis
[accessed 11.09.2020].
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in 2013 on Figure 2) [7] (Figure 1 and 2). The increasing
number of cases with strict vaccination campaigns could
be prevented.
4.4. Haemophilus Influenzae Type B (Hib)
In 2006, 28 cases were observed in Turkey when vaccination
was started, but no deaths were reported. Then, the number
of cases decreased by years and no cases have been reported
since 2013. In the United States, 8 cases were reported in
2015 and 27 cases under 5 were reported in Europe [8,9].
In some limited and hospital studies conducted in Turkey
some Hib meningitis cases were diagnosed and according to
the data provided from the Ministry, 55 cases were detected
between 2006–2017. This fact reveals the need to support
and continue the surveillance system in Turkey [10].
4.5. Mumps
In Turkey, the mumps vaccine was included in the vaccine
calendar as triple monovalent, together with measles and
rubella vaccines in 2006. There are not enough records
about mortality rates before the vaccination in Turkey but
just after the immunization in 2005 and 2006, morbidity
rates became 27. It is clear that the rate was over the line
of 25 on Figure 2 and it became almost invisible in several
years. An analysis of the data provided from the whole
country reveals that there is no death.
In one study conducted in Germany, the incidence
was found to be 10.3 per 100.000, while in another study
the incidence before vaccination was estimated to be
between 100–1000 [11,12]. As presented by Anderson et.
al., the incidence of mumps significantly decreased after
vaccination campaigns were started. In the USA, a 97%
decline was observed between 1968–1982. After vaccination
practices, the annual incidence in Finland is 1 per 100,000
[11].
Vaccination is still important for this disease, which
can still cause epidemics from time to time in the world.
According to the 2005 report, 110 out of the 193 Member
States of the WHO added the mumps vaccine into their
national vaccination programmes [13].
4.6. Rubella
There are not enough records about mortality rates for
rubella before the application of vaccination in Turkey,
but after the initiation of the immunization in 2005 and
2006, morbidity rates were 3.12 and 1.45, respectively. In
addition, it is over the line of 0 on Figure 2, and later, it
is marked on the line of 0 due to the initiating of Rubella
elimination programme. However, if we look at in Africa
and South-East Asia where the vaccination practices are at
the lowest level, still many congenital Rubella syndromes
are reported [14].
In the light of this information, it is obvious that
the only way to contain this virus, which causes many
congenital anomalies which are irreversible or requiring
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high treatment costs, is vaccination and it should be applied
rapidly in a serious manner by the other countries, while
the necessity of continuation of the current vaccination
activities is obvious in Turkey.
4.7. Hepatitis B
Hepatitis B immunization schedule launched in 1998
(Table). Since Hepatitis B mortalities are always below 1,
it is difficult to distinguish an improvement in the Figure 1.
Also, it is difficult to comment about that chronic disease,
since its morbidity level is affected by different positive
factors. However, morbidity decreased moderately after
peaking in 2005, from 12 in 2005 to 2 in 2017. The fact
that the coverage of Hepatitis B vaccine has increased by
96% from 2007 till today contributes a lot to this success
factors (Figure 1).
There are relatively different HBsAg positivity rates
in Turkey, which results from socio-cultural differences
between provinces. For example, while HBsAg positivity
was found as 12.5% in children between 2 months and 15
years of age in a study conducted in one part of Turkey, it
was found as 1.7% in children between newborns and the
ones aged 18 in a study conducted in Erzurum in 2004, and
found as 9.5% in another study conducted in Van in 2005.
The number of new hepatitis B cases in 2017 was 1571 in
Turkey. The seropositivity rate and the number of cases
indicate that studies on this subject should continue to be
carried out in the same determination level for addressing
the coverage of the vaccine [15,16,17].
4.8. Hepatitis A
Hepatitis A immunization launched in 2012 (Table). The
vaccine coverage showing Hepatitis A vaccination is not
available in the WHO database. Therefore, there is no
line belonging to Hepatitis A in the figures indicating
the immunization coverage. Hepatitis A morbidity rate
decreases moderately after having a peak in 2005, from
12.8 in 2005 to 0.58 in 2017. Mortality rate was almost 2 in
1970; however the mortality rates dropped below 0.1 after
vaccination in 2012 (Figure 1). Undoubtedly, morbidity
rates provide a better understanding of the condition of
the disease in society. The morbidity rates which were
almost 5 in 2012 and 2013 is now decreasing and still
under 1 thanks to the immunization.
4.9. Varicella
The coverage of varicella vaccination is not available in the
WHO database. Therefore, no line belonging to varicella
is marked in the figures. Varicella diagnosis leads some
confusion. A study conducted about cost-effectiveness
analysis of universal varicella vaccination in Turkey shows
age-specific reductions in varicella incidence and also
indicates that incidence under 15 years old is 2.39 while
it is mostly more than 10 for all age groups over 55. This
distribution makes it difficult for us to talk about the effect
of vaccine coverage on morbidity [18].
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The study shows that the relationship between vaccine
coverages, mortality and morbidity rates for example:
how morbidity rates of pertussis increased in 1995
when pertussis immunization coverages decreased?,
how mortality rates of neonatal tetanus increased
when tetanus coverage reduced in 1995?, and how
neonatal tetanus mortality decreased when coverages of
tetanus immünization increased in 2003?. Poliomyelitis
immunization has been at a decent level since 2007 in
the figures represented. The fact that how measles days
reduced measles morbidity has been shown. The effect of
vaccination on mumps morbidity gives a hint about the
effects of vaccination.

As a result, the data indicating how diseases and
disabilities are prevented and how the lives are saved through
immunization is presented by looking at the country’s history.
We can say that many possible outbreaks have been prevented
by vaccination studies by now and the outbreaks have been
overcome through tightly conducted vaccination campaigns,
though occassional cases have occured. In this regard, the
current study demonstrating the importance of vaccination
claims that all individuals in the society have a responsibility
in this scope when the communicable diseases and tackling
infectious diseases are the cases. The main responsibility is to
ensure that they and their children are vaccinated against the
communicable diseases which are risky for society’s health.
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